Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
45
ACHR Quote, Financials, Valuation and Earnings
Last price:
$9.49
Seasonality move
:
-13.6%
Day range:
$8.18 - $10.00
52-week range:
$2.82 - $10.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.73x
Volume:
69.7M
Avg. volume:
48.4M
1-year change:
52.08%
Market cap:
$4.1B
Revenue:
--
EPS (TTM):
-$1.31
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $21.1M | $64.3M | $171.5M | $276.4M | |
| Selling, General & Admin | -- | $3.5M | $176.7M | $165.1M | $168.4M | |
| Other Inc / (Exp) | -- | -- | -$105.8M | $17M | -$29M | |
| Operating Expenses | -- | $24.6M | $241M | $336.6M | $444.8M | |
| Operating Income | -- | -$24.6M | -$241M | -$336.6M | -$444.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$24.8M | -$347.8M | -$317.3M | -$457.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $500K | |
| Net Income to Company | -- | -$24.8M | -$347.8M | -$317.3M | -$457.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$24.8M | -$347.8M | -$317.3M | -$457.9M | |
| Basic EPS (Cont. Ops) | -- | -$0.10 | -$3.14 | -$1.32 | -$1.69 | |
| Diluted EPS (Cont. Ops) | -- | -$0.10 | -$3.14 | -$1.32 | -$1.69 | |
| Weighted Average Basic Share | -- | $240.6M | $110.8M | $240.5M | $270.4M | |
| Weighted Average Diluted Share | -- | $240.6M | $110.8M | $240.5M | $270.4M | |
| EBITDA | -- | -$24.4M | -$239.7M | -$332.2M | -$438.3M | |
| EBIT | -- | -$24.6M | -$241M | -$336.6M | -$444.8M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$24.6M | -$241M | -$336.6M | -$444.8M | |
| Operating Income (Adjusted) | -- | -$24.6M | -$241M | -$336.6M | -$444.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.7M | $23.1M | $47M | $67.8M | $89.8M | |
| Selling, General & Admin | $600K | $114.1M | $40.8M | -$21.6M | $32.3M | |
| Other Inc / (Exp) | -- | -$39M | -$4.7M | -$10.4M | $1.4M | |
| Operating Expenses | $7.3M | $137.2M | $87.8M | $46.2M | $122.1M | |
| Operating Income | -$7.3M | -$137.2M | -$87.8M | -$46.2M | -$122.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$7.3M | -$176.7M | -$91M | -$51.5M | -$115.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $100K | $100K | |
| Net Income to Company | -- | -$176.7M | -$91M | -$51.6M | -$115.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.3M | -$176.7M | -$91M | -$51.6M | -$115.3M | |
| Basic EPS (Cont. Ops) | -$0.03 | -$2.00 | -$0.38 | -$0.19 | -$0.29 | |
| Diluted EPS (Cont. Ops) | -$0.03 | -$2.00 | -$0.38 | -$0.19 | -$0.29 | |
| Weighted Average Basic Share | $240.6M | $88.4M | $240.3M | $277.7M | $397.5M | |
| Weighted Average Diluted Share | $240.6M | $88.4M | $240.3M | $277.7M | $397.5M | |
| EBITDA | -$7.3M | -$136.8M | -$86.4M | -$44.1M | -$118.8M | |
| EBIT | -$7.3M | -$137.2M | -$87.8M | -$46.2M | -$122.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$7.3M | -$137.2M | -$87.8M | -$46.2M | -$122.1M | |
| Operating Income (Adjusted) | -$7.3M | -$137.2M | -$87.8M | -$46.2M | -$122.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $52.1M | $132M | $256.1M | $342.6M | |
| Selling, General & Admin | -- | $144.3M | $154.6M | $184.7M | $150.2M | |
| Other Inc / (Exp) | -- | -$116.3M | $20.3M | -$14.6M | $24.1M | |
| Operating Expenses | -- | $196.4M | $286.6M | $440.8M | $492.8M | |
| Operating Income | -- | -$196.4M | -$286.6M | -$440.8M | -$492.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$313.2M | -$265.2M | -$443.9M | -$447.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $300K | $600K | |
| Net Income to Company | -- | -- | -$265.2M | -$444.2M | -$447.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$313.2M | -$265.2M | -$444.2M | -$447.8M | |
| Basic EPS (Cont. Ops) | -- | -$2.57 | -$1.11 | -$1.77 | -$1.31 | |
| Diluted EPS (Cont. Ops) | -- | -$2.57 | -$1.11 | -$1.77 | -$1.31 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -$273.7M | -$283.4M | -$434.9M | -$482.3M | |
| EBIT | -- | -$274.6M | -$286.6M | -$440.8M | -$492.8M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$196.4M | -$286.6M | -$440.8M | -$492.8M | |
| Operating Income (Adjusted) | -- | -$274.6M | -$286.6M | -$440.8M | -$492.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.7M | $44.6M | $112.3M | $196.9M | $263.1M | |
| Selling, General & Admin | $600K | $143.1M | $121M | $140.6M | $122.4M | |
| Other Inc / (Exp) | -- | -$116.3M | $9.8M | -$21.8M | $31.3M | |
| Operating Expenses | $7.3M | $187.7M | $233.3M | $337.5M | $385.5M | |
| Operating Income | -$7.3M | -$187.7M | -$233.3M | -$337.5M | -$385.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$7.3M | -$304.5M | -$221.9M | -$348.5M | -$338.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $300K | $400K | |
| Net Income to Company | -- | -$304.5M | -$221.9M | -$348.8M | -$338.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.3M | -$304.5M | -$221.9M | -$348.8M | -$338.7M | |
| Basic EPS (Cont. Ops) | -$0.03 | -$2.53 | -$0.93 | -$1.38 | -$0.97 | |
| Diluted EPS (Cont. Ops) | -$0.03 | -$2.53 | -$0.93 | -$1.38 | -$0.97 | |
| Weighted Average Basic Share | $240.6M | $569.7M | $718.1M | $776M | $1.1B | |
| Weighted Average Diluted Share | $240.6M | $569.7M | $718.1M | $776M | $1.1B | |
| EBITDA | -$7.3M | -$265.1M | -$230.6M | -$333.3M | -$377.3M | |
| EBIT | -$7.3M | -$265.9M | -$233.3M | -$337.5M | -$385.5M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$7.3M | -$187.7M | -$233.3M | -$337.5M | -$385.5M | |
| Operating Income (Adjusted) | -$7.3M | -$265.9M | -$233.3M | -$337.5M | -$385.5M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $36.6M | $746.6M | $69.4M | $464.6M | |
| Short Term Investments | -- | -- | -- | $461.8M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $800K | $7.6M | $9.8M | $7.9M | |
| Other Current Assets | -- | -- | $300K | $1.6M | $800K | |
| Total Current Assets | -- | $37.4M | $754.8M | $545.5M | $480.2M | |
| Property Plant And Equipment | -- | $3.9M | $10.4M | $23.4M | $66.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $2.7M | $4.5M | $7.2M | |
| Total Assets | -- | $41.8M | $768.4M | $573.8M | $554.3M | |
| Accounts Payable | -- | $2.1M | $3.4M | $3.6M | $14.3M | |
| Accrued Expenses | -- | -- | $8.5M | $27.5M | $75.1M | |
| Current Portion Of Long-Term Debt | -- | $600K | $9.5M | $9.3M | -- | |
| Current Portion Of Capital Lease Obligations | -- | $800K | $3.1M | $3.7M | $2.8M | |
| Other Current Liabilities | -- | $100K | $600K | $1.1M | $3.7M | |
| Total Current Liabilities | -- | $3.8M | $28.3M | $53.3M | $114M | |
| Long-Term Debt | -- | $300K | $9.3M | -- | $7.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $5.9M | $69.5M | $80.5M | $187.2M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -$800K | -- | |
| Common Equity | -- | $35.9M | $698.9M | $493.3M | $367.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $35.9M | $698.9M | $493.3M | $367.1M | |
| Total Liabilities and Equity | -- | $41.8M | $768.4M | $573.8M | $554.3M | |
| Cash and Short Terms | -- | $36.6M | $746.6M | $531.2M | $464.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $796.2M | $112.5M | $461.4M | $501.7M | |
| Short Term Investments | -- | -- | $488.1M | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $1.1M | $10.8M | $3.9M | $11M | |
| Other Current Assets | -- | $400K | $1M | $3.1M | $3.6M | |
| Total Current Assets | -- | $797.7M | $615.3M | $475.7M | $523M | |
| Property Plant And Equipment | -- | $7M | $21M | $59.4M | $120.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $400K | $400K | $400K | |
| Other Long-Term Assets | -- | $500K | $900K | $4.1M | $7.6M | |
| Total Assets | -- | $805.7M | $637.6M | $539.6M | $651.5M | |
| Accounts Payable | -- | $19.4M | $5.2M | $15.6M | $23.5M | |
| Accrued Expenses | -- | -- | $17.1M | $78.4M | $34M | |
| Current Portion Of Long-Term Debt | -- | $7M | $9.4M | $2.3M | -- | |
| Current Portion Of Capital Lease Obligations | -- | $1.7M | $4.1M | $2.9M | $3.6M | |
| Other Current Liabilities | -- | $1.6M | $900K | $2.8M | $3.5M | |
| Total Current Liabilities | -- | $29.7M | $43.8M | $117M | $86.7M | |
| Long-Term Debt | -- | $11.7M | $2.3M | -- | $64M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $83.8M | $80.4M | $175.1M | $183.8M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -$1.2M | -- | -$100K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $721.9M | $557.2M | $364.5M | $467.7M | |
| Total Liabilities and Equity | -- | $805.7M | $637.6M | $539.6M | $651.5M | |
| Cash and Short Terms | -- | $796.2M | $600.6M | $461.4M | $501.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$24.8M | -$347.8M | -$317.3M | -$457.9M | |
| Depreciation & Amoritzation | -- | $200K | $1.3M | $4.4M | $6.5M | |
| Stock-Based Compensation | -- | $200K | $123.6M | $102.8M | $45.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$22.8M | -$108.4M | -$200.4M | -$271.6M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$1.9M | -$3.5M | -$464.3M | $420.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $900K | $20M | -- | $7.5M | |
| Long-Term Debt Repaid | -- | -- | -- | -$10M | -$10M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $201.6M | -- | -$11M | |
| Cash From Financing | -- | $51.2M | $822.2M | -$9.9M | $250.1M | |
| Beginning Cash (CF) | -- | $10.1M | $36.6M | $746.9M | $72.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $26.5M | $710.3M | -$674.6M | $399.2M | |
| Ending Cash (CF) | -- | $36.6M | $746.9M | $72.3M | $471.5M | |
| Levered Free Cash Flow | -- | -$24.7M | -$111.9M | -$207.3M | -$315.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$176.7M | -$91M | -$51.6M | -$115.3M | |
| Depreciation & Amoritzation | -- | $400K | $1.4M | $2.1M | $3.3M | |
| Stock-Based Compensation | -- | $102.8M | $26.2M | -$27.4M | $21.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$30.7M | -$50.8M | -$66.8M | -$97.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$1.1M | -$489.1M | -$15.8M | -$19.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $20M | -- | -- | $31.7M | |
| Long-Term Debt Repaid | -- | -- | -$2.5M | -$2.5M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $201.6M | -- | -$6M | -$7.4M | |
| Cash From Financing | -- | $822.1M | -$2.4M | $136.5M | $258.1M | |
| Beginning Cash (CF) | -- | $5.9M | $657.7M | $414.8M | $367.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $790.3M | -$542.3M | $53.9M | $141.3M | |
| Ending Cash (CF) | -- | $796.2M | $115.4M | $468.7M | $508.4M | |
| Levered Free Cash Flow | -- | -$31.8M | -$52.3M | -$82.6M | -$116.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$265.2M | -$444.2M | -$447.8M | |
| Depreciation & Amoritzation | -- | -- | $3.2M | $5.9M | $10.5M | |
| Stock-Based Compensation | -- | $104.7M | $95.2M | $51.3M | $105.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$182.1M | -$254.8M | -$348.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$491.7M | $456.6M | -$66.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $65M | |
| Long-Term Debt Repaid | -- | -- | -$7.5M | -$10M | -$2.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$9.5M | |
| Cash From Financing | -- | -- | -$7M | $151.5M | $454.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$680.8M | $353.3M | $39.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$186.2M | -$293.4M | -$415M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$304.5M | -$221.9M | -$348.8M | -$338.7M | |
| Depreciation & Amoritzation | -- | $800K | $2.7M | $4.2M | $8.2M | |
| Stock-Based Compensation | -- | $104.7M | $76.3M | $24.8M | $84.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$59.5M | -$133.2M | -$187.6M | -$264.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$3M | -$491.2M | $429.7M | -$57.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $20M | -- | -- | $57.5M | |
| Long-Term Debt Repaid | -- | -- | -$7.5M | -$7.5M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $201.6M | -- | -$9.5M | -$8M | |
| Cash From Financing | -- | $822.1M | -$7.1M | $154.3M | $358.9M | |
| Beginning Cash (CF) | -- | $66M | $2.1B | $793.5M | $1.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $759.6M | -$631.5M | $396.4M | $36.9M | |
| Ending Cash (CF) | -- | $825.6M | $1.5B | $1.2B | $1.3B | |
| Levered Free Cash Flow | -- | -$62.5M | -$136.8M | -$222.9M | -$322M | |
Get ACHR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ACHR
Sector
P/E ratio
--
17.94x
PEG ratio
--
0.34x
P/B ratio
8.73x
1.76x
Price / LTM sales
--
0.97x
Growth Metrics
ACHR
Sector
Revenue growth
--
1.77%
Earnings growth
--
1.67%
Revenue (5-year growth)
--
4.31%
Earnings forecast
-$0.26
$0.46
Profitability
ACHR
Sector
Profitability FY 2024
--
$434.2M
Return on invested capital
--
5.93%
Return on assets
--
3.69%
Return on equity
--
8.87%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
6
Balance Sheet
ACHR
Sector
Total cash
$501.7M
$170.4M
Short term investments
--
$46.5M
Total assets
$554.3M
$2.1B
Long term debt
--
$147.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
